Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can VR and mixed reality help stroke survivors move better?

NCT ID NCT05903235

Symptom relief Sponsor: Chang Gung Memorial Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two new therapy systems that use virtual reality (VR) or mixed reality (MR) to help stroke survivors improve arm function. Participants will perform movements while watching a mirrored hand in a headset. The trial aims to see if these high-tech approaches are feasible and more effective than traditional mirror therapy for daily activities.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual Reality-based Mirror Therapy and Mixed Reality-based Mirror Therapy
What this could lead to
If successful, this could provide engaging, technology-based rehab options that improve arm movement and daily independence after stroke.
What could go wrong
This is a small, early feasibility study with only 45 participants. The technology may not work for everyone, and benefits over traditional therapy are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Phase Ⅰ: Design and Development of the VR+MT and MR+MT Systems \& Feasibility Study Inclusion Criteria: * diagnosed with unilateral stroke * age of 20 to 80 years * a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60 * able to follow the study instructions and provide the feedback of user experiences verbally Exclusion Criteria: * diagnosed with global or receptive aphasia * the presence of severe neglect * the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory perception Phase Ⅱ: Validation and Comparison of Clinical Treatment Efficacy Inclusion Criteria: * diagnosed with unilateral stroke * more than 6 months after stroke onset * age of 20 to 80 years * a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60 * able to follow the study instructions * capable of participating in the assessment process and treatment program Exclusion Criteria: * diagnosed with global or receptive aphasia * the presence of severe neglect * the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory perception

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Central nervous system diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

central nervous system disorder cerebrovascular disorder stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Central nervous system diseases Cerebrovascular disorders Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Taoyuan Chang Gung Memorial Hospital

    RECRUITING

    Taoyuan City, 333, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.